Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Key Driver in Gastric Cancer Progression Uncovered
August 2025
A new review highlights the growing role of fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
Read more
16 Dec 2015
ESMO Asia 2015 Congress
LUGANO/SINGAPORE, 16 December 2015 – ESMO, the leading professional organisation for medical oncology, is pleased to announce the inaugural ESMO Asia…
15 Dec 2015
New SEER Registry “Big Data” Demonstrates the Oncotype DX® Test Accurately Predicts Clinical Breast Cancer Outcomes, Bringing the Total Number of Patients in Prospective Outcome Studies to 50,000
GENEVA, Switzerland, [December 14, 2015] – Genomic Health today announced results from multiple Oncotype DX® breast cancer test studies at the…
24 Nov 2015
SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms
SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…
16 Nov 2015
Revolutionary Computer Program Diagnoses Cancer in 2 Days
NOVEL diagnostic technology based on advanced self-learning computer algorithms may identify the source of cancer in a patient with 85% certainty…
12 Nov 2015
New German Data Show the Use of Endocuff Vision® May Improve Adenoma Detection Rates and Reduce Health System Costs
London, Wednesday 11 November 2015, 07:00 GMT: Norgine B.V. today announced new data showing that ENDOCUFF VISION®, a colonoscope device…
1 Oct 2015
Large TAILORx Outcomes Study Demonstrates 99% of Patients with Low Oncotype DX® Recurrence Score® Results Were Breast Cancer Relapse-Free following Five Years of Hormone Therapy Alone
GENEVA, Switzerland, [September 28, 2015] – Genomic Health today announced the presentation of the first results1 from the Trial Assigning…
24 Sep 2015
NICE Recommends Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia
London, 24 September 2015 – Gilead Sciences’ Zydelig® (idelalisib) has today been recommended by the National Institute for Health and Care Excellence…
17 Aug 2015
More Reliable Prostate Cancer Diagnoses Provided by Sensor Chip
PROSTATE cancer (PrC) diagnosis may become more efficient and reliable thanks to a new sensor chip, according to recent study data.
Loading posts...
« Previous
1
…
47
48
49
50
51
52
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View